Low‐frequency subthalamic nucleus stimulation in Parkinson's disease: A randomized clinical trial
Hui Ming Khoo(The University of Osaka), Toshiki Yoshimine(Kishokai Medical Corporation), Haruhiko Kishima(Osaka University Hospital), Youichi Saitoh(The University of Osaka), Satoru Oshino(The University of Osaka), Koichi Hosomi(RELX Group (Netherlands)), Hideki Mochizuki(Juntendo University), Toshio Shimokawa(Osaka University Hospital), Masaru Yokoe(The University of Osaka), Tomoyuki Maruo(The University of Osaka), Naoki Tani(Osaka Gakuin University)
Cited by 104
Related Papers
PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria
|Nature Communications|2012|599
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
|The Lancet|2014|436
MEIOSIN Directs the Switch from Mitosis to Meiosis in Mammalian Germ Cells
|Developmental Cell|2020|211